It’s a congressional letdown that highlights the difficulty of legislating in a divided Washington and in taking on the powerful pharmaceutical industry. In other pharmaceutical news: doctors' financial links to pharma, Medicaid approval for a sickle cell treatment, the Ebola vaccine, and electronic records.
from Kaiser Health News https://ift.tt/34TwHo5
December 23, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Perspectives: We Need To Bring Down The Cost Of Developing Miracle CuresRead recent commentaries about drug-cost issues. from Kaiser Health News https://ift.tt/2FolCCe … Read More
University Of Illinois At Chicago Acknowledged Failure To Catch Warnings Signs Over Child Psychiatrist Who Violated Research ProtocolsAccording to new documents, the University of Illinois at Chicago Institutional Review Board, the committee responsible for protecting research subjects, improperly fast-tracked approval of Dr. Mani Pavuluri’s clinical trial,… Read More
HHS Has Been Deluged With Comments Over PBMs And Drug Rebates. Who Is Stoking That Fervent Response?News outlets report on stories related to pharmaceutical pricing. from Kaiser Health News https://ift.tt/2HHLRFi … Read More
State Highlights: PG&E Knew About Likelihood Of Flaws That Led To Calif. Fires, Report Says; San Francisco Proposes Sweeping Limits On E-Cigarette SalesMedia outlets report on news from California, Washington, Wyoming, Kansas, Michigan, Pennsylvania, Wisconsin, Arizona, Florida, Ohio, Connecticut, New York, Georgia, Louisiana and Texas. from Kaiser Health News https://ift.t… Read More
From The State Capitols: Public Option Bills Clear Key Hurdle In Conn. Legislature; Measure Would Encourage Ga. Schools To Expand RecessNews from state legislatures comes out of Connecticut, Georgia and Massachusetts. from Kaiser Health News https://ift.tt/2HHLNW4 … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment